MyBiotech is a CDMO on the fields of Biotechnology and Pharmaceuticals.
Biotechnological production is covered with all aspects of upstream and downstream processes focusing on cell disruption with our propriety technology and purification with chromatographic methods such as ion exchange and supercritical fluid chromatography. Biotechnological production of active pharmaceutical ingredients and natural substances is also one of the core aspects of our business. Our products include Algae derived Omega-3 fatty acids, innovative Omega-3 formulations Curcumin, Phycocyanin along with plant derived natural supplements.
Pharmaceutical division is specialized on development and technology transfer of nanoparticle and microparticle formulations from concept through development all the way up to GMP manufacturing. We are continuously developing and adapting innovative production methods for GMP manufacturing and processing of particulate systems. We support you with our innovative technologies to bring your project one step closer to success.
Merger of MyBiotech and MJR PharmJet under the roof of MyBiotech GmbH
Foundation of the MyBiotech GmbH
Expansion, purchase and conversion of the Überherrn industrial campus, relocation
Foundation of Instillo GmbH; re-organization and transfer of administrative tasks and IP rights
Patenting of MJR-based processes in the pharmaceutical field
Application of MJR in the pharmaceutical sector by Dr. Emre Türeli, foundation of MJR PharmJet GmbH, Starterzentrum Homburg
Invention of the MicroJet Reactor (MJR) by Dr. Bernd Penth